SOLS

SOLS, founded in 2013, uses state-of-the-art computer vision and machine learning to improve the fit and functionality of footwear. Backed by blue-chip investors such as Founders Fund, Lux Capital, and Tenaya Capital, we are based in New York City. To date, the company has launched two products: SOLSRx, a medical-grade 3D printed orthotic, and ExoSOLS, custom insoles sold directly to consumers. SOLS now leverages its patented footwear customization software to address one of the biggest issues in the footwear industry—returns related to sizing. Our products sit at the intersection of technology and the human body. We are paving the way for mass customization.